The roles of IDH1 in tumor metabolism and immunity.

Yingqian Ni, Peibo Shen, Xingchen Wang, He Liu, Huiyuan Luo, Xiuzhen Han

Future oncology (London, England) 2022 Nov

filter terms:

IDH1 is a key metabolic enzyme for cellular respiration in the tricarboxylic acid (TCA) cycle that can convert isocitrate into α-ketoglutarate (α-KG) and generate NADPH. The reduction of IDH1 may affect dioxygenase activity and damage the body's detoxification mechanism. Many studies have shown that IDH1 is closely related to the occurrence and development of tumors, and the changes in IDH1 expression levels or gene mutations have appeared in many tumor tissues and produced a series of metabolic and immunity changes at the same time. To better understand the relationship between IDH1 and tumor development, this article reviews the latest advances in IDH1 and tumor metabolism, tumor immunity, IDH1 regulatory mechanisms and IDH1 target inhibitors.

Citation

Yingqian Ni, Peibo Shen, Xingchen Wang, He Liu, Huiyuan Luo, Xiuzhen Han. The roles of IDH1 in tumor metabolism and immunity. Future oncology (London, England). 2022 Nov;18(35):3941-3953